| Authors: |
Desai JV; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Urban A; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Swaim DZ; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Colton B; Pharmacy Department, NIH Clinical Center, NIH, Bethesda, MD, USA., Kibathi LW; Pharmacy Department, NIH Clinical Center, NIH, Bethesda, MD, USA., Ferrè EMN; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Stratton P; Office of the Clinical Director, National Institute of Neurological Disease and Stroke, NIH, Bethesda, MD, USA., Merideth MA; National Human Genome Research Institute, NIH, Bethesda, MD, USA., Hunsberger S; Biostatistics Research Branch, Division of Clinical Research (DCR), NIAID NIH, Bethesda, MD, USA., Matkovits T; Matinas BioPharma Nanotechnologies Inc., Bedminster NJ, USA., Mannino R; Matinas BioPharma Nanotechnologies Inc., Bedminster NJ, USA., Holland SM; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Tramont E; NIAID, NIH, Bethesda, MD, USA., Lionakis MS; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Freeman AF; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. |
